OpenAI and Amazon in $38 billion cloud deal
Wall Street Breakfast
Seeking Alpha
3.8 • 950 Ratings
🗓️ 3 November 2025
⏱️ 4 minutes
🧾️ Download transcript
Summary
Show Notes
Hedge funds wrong-footed by Mag 7 earnings
Episode transcripts seekingalpha.com/wsb. Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Seeking Alpha's Wall Street Lunch, our afternoon update on today's market action, news, and analysis. |
| 0:09.7 | Good afternoon. Today is Monday, November 3rd, and I'm your host, Kim Kahn. Our top story so far, |
| 0:15.8 | OpenAI announced that it has signed a deal with Amazon Web Services worth $38 billion to help supply it with hundreds of thousands of Nvidia's GPUs. |
| 0:24.8 | As part of the seven-year deal, OpenAI will get access to Amazon Web Services for hundreds of thousands of Nvidia's GPUs, |
| 0:31.4 | with the ability to expand to tens of millions of CPUs to rapidly scale its agenetic workloads. |
| 0:37.7 | AWS will give OpenAI access to its Amazon EC2 Ultra servers to help with the workload. |
| 0:43.7 | OpenAI said in a blog post, |
| 0:45.6 | AWS has unusual experience running large-scale AI infrastructure securely, reliably, and at scale, |
| 0:52.2 | and that the deal will help millions of users continue to get value |
| 0:55.4 | from ChatGPT. When asked for a comment, ChatGPT said the deal is OpenAI's Declaration |
| 1:00.9 | of Adulthood as it ends its monogamous relationship with Microsoft. Meanwhile, Loop Capital |
| 1:06.0 | put a new Wall Street-high price target of $350 per share on NVIDIA, up from 250. At that price, the AI |
| 1:13.2 | chip giant would have a market cap that would have other mega caps reeling at $8.5 trillion. |
| 1:19.0 | Analyst Ananda Baru said he believes that NVIDIA is about to see a surge in GPU shipments |
| 1:23.9 | over the next 12 to 15 months, aided by its GB200 NVL 72 racks. |
| 1:29.3 | In other news of note, Kleenex teams up with Tylenol. Kimberly Clark is buying Consumer |
| 1:34.9 | Health Company Kenview in a cash in stock deal that values Kenview at $48.7 billion. |
| 1:39.8 | Shares of Kimberly Clark, which owns such iconic brands as Kleenex, Huggies, and Scots are tumbling |
| 1:45.7 | more than 10%, while Kenview, which is split from Johnson and Johnson, is up nearly 20%. |
| 1:51.4 | Along with brands like Listerine and Band-Aid, Kenvue owns Tylenol, which has faced recent |
| 1:56.3 | controversy with Health Secretary Robert F. Kennedy Jr. and President Donald Trump |
| 2:00.7 | saying that the painkiller could cause autism. RF Kennedy Jr. and President Donald Trump saying that the |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Seeking Alpha, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Seeking Alpha and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.